Illumina's results reveal worrying signs for the consumer genetics industry

What is it?

STAT Plus is STAT's premium subscription service for in-depth coverage and analysis of the biotechnology, pharmaceutical, policy and life science sectors.
Our award-winning team covers Wall Street news, political developments in Washington, early scientific breakthroughs and clinical trial results, as well as disruption of healthcare in Silicon Valley and beyond.

What is included?

• Daily report and analysis
• The most comprehensive coverage of the sector by a powerful team of journalists
• Subscriber-only newsletters
• Daily newsletters to inform you about the most important news of the day's industry
• Intelligence Briefings Online
• Frequent opportunities to interact with experienced journalists and industry experts
• Exclusive events in the industry
• Premium access to networking events for subscribers across the country
• The best reporters in the industry
• The most trusted and connected newsroom in the healthcare industry
• And much more
• Exclusive interviews with industry leaders, profiles and high-end tools, such as our CRISPR Trackr.